Physicochemical Properties
Molecular Formula | C21H42CLNO2 |
Molecular Weight | 376.02 |
Exact Mass | 375.29 |
CAS # | 147228-80-6 |
PubChem CID | 91659090 |
Appearance | Typically exists as solid at room temperature |
Melting Point | 44 °C |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 13 |
Heavy Atom Count | 25 |
Complexity | 240 |
Defined Atom Stereocenter Count | 0 |
SMILES | [Cl-].O.O.[N+](C)(C)(CC1C=CC=CC=1)CCCCCCCCCCCC |
InChi Key | ORJHCWPHEPKXRE-UHFFFAOYSA-M |
InChi Code | InChI=1S/C21H38N.ClH.2H2O/c1-4-5-6-7-8-9-10-11-12-16-19-22(2,3)20-21-17-14-13-15-18-21;;;/h13-15,17-18H,4-12,16,19-20H2,1-3H3;1H;2*1H2/q+1;;;/p-1 |
Chemical Name | benzyl-dodecyl-dimethylazanium;chloride;dihydrate |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | MIC: 20 mg/L (P. fluorescens)[1] |
ln Vitro | The percentage population of dead rat thymocyte cells varies in a dose-dependent manner in response to benzoyldodecyldimethylammonium chloride dihydrate (1–10 μM; 2 hours)[1]. With a MIC of 20 mg/L, benzoyldodecyldimethylammonium chloride dihydrate (0–40 mg/L; 0–24 hours) inhibits P. fluorescens. Cells grow in the same way as the control at 5 mg/L. The growth profile differs from the control at doses of 10 and 15 mg/L, and the cells don't begin to develop until eight hours after adaption. BDMDAC inhibits cell proliferation at doses ≥20 mg/L[2]. As evidenced by phenomena like membrane disruption and loss of membrane integrity with subsequent leakage of vital intracellular constituents, benzododecyldimethylammonium chloride dihydrate exhibits strong concentration-dependent interactions with cell surfaces and binds to microbial membrane surfaces via ionic and hydrophobic interactions[2]. These interactions promote significant and irreversible changes in the structure of the cell. |
Cell Assay |
Cell Viability Assay[1] Cell Types: Rat thymocyte cells Tested Concentrations: 0, 5, 10, 15, 20 and 40 mg/L Incubation Duration: 2 hrs (hours) Experimental Results: Resulted in cell death. Cell Proliferation Assay[1] Cell Types: Bacterial P. fluorescen Tested Concentrations: 0, 5, 10, 15, 20 and 40 mg/L Incubation Duration: 2 hrs (hours) Experimental Results: Inhibited bacterial growth in a time and dose dependent manner. |
References |
[1]. Sadegh Ghanbar, et al. New Generation of N-Chloramine/QAC Composite Biocides: Efficient Antimicrobial Agents To Target Antibiotic-Resistant Bacteria in the Presence of Organic Load. ACS Omega. 2018 Aug 22;3(8):9699-9709. [2]. Tsuyoshi Mitani, et al. Zinc-related actions of sublethal levels of benzalkonium chloride: Potentiation of benzalkonium cytotoxicity by zinc. Chem Biol Interact. 2017 Apr 25;268:31-36. |
Solubility Data
Solubility (In Vitro) |
DMSO : 100 mg/mL (265.94 mM) H2O : ≥ 100 mg/mL (265.94 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.65 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.65 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (6.65 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.6594 mL | 13.2972 mL | 26.5943 mL | |
5 mM | 0.5319 mL | 2.6594 mL | 5.3189 mL | |
10 mM | 0.2659 mL | 1.3297 mL | 2.6594 mL |